Kimberly Mendes

Kimberly Mendes has extensive experience in the biotechnology and healthcare industry. Kimberly is currently working as the Director of Biologics Analytical Development at AVEO Oncology. Prior to this, they held the position of Director of Analytical and Formulation Development at Senda Biosciences.

From 2017 to 2021, Mendes worked at Goodwin Biotechnology, Inc. in various roles, including Director of Analytical Development and Bioconjugation Process Development, as well as Senior Manager of Protein Characterization and Bioconjugation Process Development. Here, they led teams responsible for developing and testing biologics using various analytical techniques and was involved in the scale-up of bioconjugation processes.

Before joining Goodwin Biotechnology, Mendes worked at OPKO Health, Inc. as a Senior Scientist, managing a team that screened chemical libraries to identify disease biomarkers for diagnostic purposes. Kimberly also worked at The Scripps Research Institute as a Staff Scientist and Postdoctoral Research Scientist, where they conducted research on peptoid libraries and their potential therapeutic applications.

Mendes' career began at Boston College, where they worked as a Graduate Research Associate, focusing on the allosteric interactions of nucleotide effector molecules in E. coli. Kimberly also worked as a Research Technician at Natick Army Laboratories, conducting comparative analysis and bacterial contamination detection in food samples.

Overall, Kimberly Mendes has a diverse range of experience in analytical development, bioconjugation, diagnostics, and research, making their a valuable asset in the biotechnology and healthcare field.

Kimberly Mendes completed their education in a chronological order, starting from 2001 to 2010. Kimberly attended Boston College from 2001 to 2005, where they obtained a Bachelor of Science (B.S.) degree in Chemistry and Economics. Following this, from 2005 to 2010, they pursued further education at the same institution, Boston College, and earned a Doctor of Philosophy (Ph.D.) degree in Biochemistry.